Longevity Papers Podcast

In this episode of Longevity Papers, we critically analyze five cutting-edge research papers for biotech researchers and longevity enthusiasts:

1) "Muscle peripheral circadian clock drives nocturnal protein degradation via raised Ror/Rev-erb balance and prevents premature sarcopenia" (Kelu, Hughes, King's College London, May 05, 2025, https://pubmed.ncbi.nlm.nih.gov/40324...) - We explore how the muscle's intrinsic clock regulates protein degradation pathways (UPS and autophagy) at night, with clock disruption causing initial muscle growth but accelerating sarcopenia. The zebrafish model reveals the Ror/Rev-erb balance as a potential therapeutic target.

2) "Fucoidans are senotherapeutics that enhance SIRT6-dependent DNA repair" (Zhang et al., University of Minnesota, April 28, 2025, https://www.biorxiv.org/content/10.11...) - We examine how these brown algae compounds activate SIRT6 to reduce cellular senescence and enhance DNA repair in accelerated aging mice. We discuss the study's limitations including the lack of lifespan data in normal aging models and the need for standardized fucoidan formulations.

3) "Genetic correlation-guided mega-analysis of DO mice provides mechanistic insight for age-related pathologies" (Mullis et al., Calico Life Sciences, May 17, 2025, https://www.biorxiv.org/content/10.11...) - We analyze this comprehensive study of 7,233 phenotypes in Diversity Outbred mice, which challenges existing paradigms by showing weak correlation between lifespan and frailty genetics while highlighting immune cell composition as a key factor.

4) "The broccoli derivative sulforaphane extends lifespan by slowing the transcriptional aging clock" (Sedore et al., University of Oregon, May 16, 2025, https://www.biorxiv.org/content/10.11...) - We investigate how this natural compound extends C. elegans lifespan by 50% through hormetic detoxification pathways, while questioning the translational relevance and proposing mammalian validation studies.

5) "AI-Driven Identification of Exceptionally Efficacious Polypharmacological Compounds That Extend Lifespan" (Avchaciov et al., Gero PTE, April 22, 2025, https://pubmed.ncbi.nlm.nih.gov/40260...) - We review how AI-designed multi-target compounds achieved remarkable lifespan extension in C. elegans, representing a paradigm shift in geroprotector development.

Throughout the episode, we delve into experimental methods, interpret figures beyond the abstracts, maintain healthy skepticism toward preliminary findings, and propose crucial follow-up studies to validate or challenge each paper's conclusions.

Paper Title: Boosting Cellular Longevity Through Intracellular ATP Modulation

Authors: Naci Oz, Hetian Su, Praveen Patnaik, Derek C. Prosser, Vyacheslav M. Labunskyy, Rohil Hameed, Vadim N. Gladyshev, Nan Hao, Alaattin Kaya

Institution: University of Virginia, University of California San Diego, Boston University, Harvard Medical School

Date: April 16, 2025

Link: https://www.biorxiv.org/content/10.1101/2025.04.14.648769v1

Key Findings:

Engineered yeast with a parasitic ATP transporter (NTT1) showed ATP depletion shortens lifespan, while supplementation extends it. Dual mechanisms: mitochondrial suppression (catabolism) and extracellular ATP sensing (MAPK activation).

40% lifespan extension in NTT1 yeast (p=4.03E-18), but high-dose ATP caused toxicity in mitochondrial-competent cells (Fig 6B).

Limitations: Yeast models lack human aging complexity (e.g., inflammation, systemic decline).

Next Steps: Validate in mammals, identify ATP-sensing receptors, test combinatorial therapies (e.g., ATP + rapamycin).

Paper Title: HDAC11 Deficiency Regulates Age-Related Muscle Decline and Sarcopenia

Authors: Renato Odria, Aina Cardús, Clara Gomis-Coloma, Ulalume Hernández-Arciga, Ceda Stamenkovic, Shweta Yadav

Institution: Institut d'Investigació en Ciències de Salut Germans Trias i Pujol, Spain

Date: April 12, 2025

Link: https://pubmed.ncbi.nlm.nih.gov/40220154/

Key Findings:

HDAC11-deficient aged mice resisted sarcopenia: 26% larger type IIb muscle fibers (p less than 0.0001), 55% fewer lipid droplets (Fig 6B), and ω-6/ω-3 ratio reversal (3.5 → 1.8).

50% increase in PAX7⁺ satellite cells post-injury, suggesting enhanced regeneration.

Limitations: Small cohort (n=19 KO mice), survival bias (0% mortality vs. 27% in WT), no dietary controls.

Next Steps: Muscle-specific KO models, lysine-myristoylation proteomics, in vivo electrophysiology.

Comparative Insights:

Both studies target metabolic pathways (ATP/HDAC11) but lack translational rigor.

Yeast highlights energy flux; mice emphasize lipid/metabolic reprogramming.

Critical gap: Human relevance unproven. Prioritize muscle-specific and dose-controlled studies.

Paper: Epigenetic editing at individual age-associated CpGs affects the genome-wide epigenetic aging landscape.

Authors: Liesenfelder, S., Elsafi Mabrouk, M.H., Iliescu, J. *et al.*. The corresponding author is Wolfgang Wagner.

Journal: Nature Aging

Published: 24 March 2025.

DOI: https://doi.org/10.1038/s43587-025-00841-1 (This DOI can be used to access the paper.)

This week, we delve into a fascinating paper from Nature Aging that explores the impact of **epigenetic editing at individual age-associated CpG sites on the broader epigenetic aging landscape**. Researchers, including S. Liesenfelder and Wolfgang Wagner, utilized CRISPR-based editing tools (dCas9-DNMT3A, CRISPRoff) to target specific CpG sites and observed **genome-wide methylation changes, termed "bystander effects"**. These effects were found to be **reproducible and linked to 3D chromatin interactions**. Notably, **hypermethylation at age-associated sites showed greater stability compared to hypomethylated targets**.

This paper raises some critical questions for the longevity biotech field:

As one talking point suggests, **"If aging is an orchestra, this paper shows the musicians talk to each other—but we still don’t know who’s the conductor"**. How do these localized epigenetic edits propagate and influence the wider genome?

Another point to consider: **"Editing one CpG is like poking a spiderweb: the whole structure vibrates, but does it matter for the spider?"**. Are these genome-wide changes functionally significant for the aging process?

The study uses **epigenetic clocks**, which are highlighted as **"like a car’s dashboard warning lights. Fixing the light doesn’t fix the engine"**. Does altering these clocks through epigenetic editing truly impact the underlying mechanisms of aging, or are we just tweaking a biomarker?

While the paper demonstrates these bystander effects, it's important to consider the magnitude of the changes, with opinions noting that the hyper-CpG changes in Fig 5ab may not be that impressive.

The relevance of epigenetic clocks for interventions also needs scrutiny, as they are not yet fully validated for this purpose.

There's potential for applying information theory and compression concepts to better understand the communication within this epigenetic network.

We will discuss the potential implications of these "bystander effects" and consider the limitations of using epigenetic clocks as direct targets for anti-aging therapies, especially in the absence of more supporting research. We will also briefly touch on related research in epigenetic editing and its broader applications.

Inhibition of Ferroptosis Delays Aging and Extends Healthspan Across Multiple Species (March 31, 2025)

Institution: Southwest Medical University, Luzhou, Sichuan, China

Relevance: The study finds that ferroptosis—a form of iron-dependent cell death—is a key driver of cellular senescence. Inhibiting ferroptosis extends lifespan and improves healthspan in both C. elegans and mice. The cross-species effects are compelling, yet long-term safety and broader applicability remain to be explored.

• Doxifluridine Promotes Host Longevity through Bacterial Metabolism (March 31, 2025)

Institution: West China Hospital, Sichuan University, Chengdu, China

Relevance: Using a dual-fluorescent splicing reporter in C. elegans, this research identifies doxifluridine as a lead compound that rescues age-related alternative splicing defects—its efficacy being dependent on bacterial metabolism. This host–microbe interplay opens a novel therapeutic avenue but needs further mechanistic validation in higher organisms.

• Neuronal Antenna Senses Signals from the Bone to Sustain Cognition by Boosting Autophagy (April 2025)

Institution: Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, Paris, France

Relevance: This study shows that bone-derived BGLAP/osteocalcin acts via an “extracellular antenna” in hippocampal neurons to enhance autophagy and improve cognitive resilience in aging. While promising in linking systemic factors to brain health, its overall impact on lifespan extension is still uncertain.

• Senescent Endothelial Cells in Cerebral Microcirculation Are Key Drivers of Age-Related Blood-Brain Barrier Disruption, Microvascular Rarefaction, and Neurovascular Coupling Impairment in Mice (April 2025)

Institution: University of Oklahoma Health Sciences Center

Relevance: The paper demonstrates that senescent endothelial cells contribute to neurovascular decline, disrupting the blood-brain barrier and impairing cognitive function. It suggests that targeting these cells could restore neurovascular health in aging, although caution is warranted given the variable results of senolytic interventions.

• Single Cell-Resolved Cellular, Transcriptional, and Epigenetic Changes in Mouse T Cell Populations Linked to Age-Associated Immune Decline (March 31, 2025)

Institution: Regeneron Pharmaceuticals, Tarrytown, NY, USA

Relevance: This comprehensive single-cell analysis maps how T cell populations change with age, pinpointing alterations that may underlie immune decline. These insights could pave the way for targeted interventions to rejuvenate immune function in the elderly, though translation to human systems will be a major challenge.

For a deep dive in our discussion, we'll focus on the doxifluridine and ferroptosis inhibition studies—both of which offer novel, cross-species strategies that might translate into significant longevity gains if further validated.

Note: While each paper provides valuable mechanistic insights, the overall picture suggests these findings are incremental and require additional corroboration to be considered game-changing in the field of longevity research.

Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell

Types and Protect Against Senescence

Lu, J., Rao, S. R., Knowles, H. ... · cell biology · Botnar Research

Centre, Nuffield Department of Orthopaedics, Rheumatology and

Musculoskeletal Sciences, University of Oxford, Oxford, UK · biorxiv

Longevity Relevance Analysis (5)

Bisphosphonates may trigger anti-aging effects by protecting against

cellular senescence and modifying the plasma proteome. The paper

addresses mechanisms that could potentially influence the root causes

of aging, rather than merely treating age-related diseases.

Wednesday, March 26, 2025

[11]Targeted intervention of senescence induced by a 5' half fragment

of tRNASec(NCA) with antisense oligonucleotide extends healthspan and

lifespan in mice

Cao, K.-Y., Bai, L.-B., Zhang, D. ... · genetics · State Key Laboratory

of Quality Research in Chinese Medicine, Macau University of Science

and Technology · biorxiv

Longevity Relevance Analysis (5)

The paper claims that targeting the 5'-tRNASec(NCA) half with antisense

oligonucleotides can ameliorate aging markers and extend healthspan and

lifespan in mice. This research addresses a potential root cause of

aging by identifying tRNA damage as a novel aging hallmark and

proposing a therapeutic intervention, which is significant for the

field of longevity research.

Tuesday, March 25, 2025

[17]Epigenetic editing at individual age-associated CpGs affects the

genome-wide epigenetic aging landscape.

Sven Liesenfelder, Mohamed H Elsafi Mabrouk, Jessica Iliescu ... ·

Nature aging · Institute for Stem Cell Biology, RWTH Aachen University

Medical School, Aachen, Germany. · pubmed

Longevity Relevance Analysis (5)

The paper claims that epigenetic editing at age-associated CpG sites

can modulate the epigenetic aging network and interfere with epigenetic

clocks. This research is relevant as it explores the mechanisms of

aging at the epigenetic level, potentially addressing the root causes

of aging rather than merely treating age-related diseases.

Saturday, March 22, 2025

[45]Exosomes Released from Senescent Cells and Circulatory Exosomes

Isolated from Human Plasma Reveal Aging-associated Proteomic and Lipid

Signatures

Patel, S. K., Bons, J., Rose, J. P. ... · cell biology · Buck Institute

for Research on Aging · biorxiv

Longevity Relevance Analysis (5)

The paper identifies specific proteomic and lipidomic signatures in

exosomes from senescent cells and human plasma that are associated with

aging. This research is relevant as it explores the mechanisms of

cellular senescence, which is a fundamental process in aging and

age-related diseases, potentially leading to therapeutic targets for

longevity interventions.

Wednesday, March 26, 2025

[15]SIRT6 activator fucoidan extends healthspan and lifespan in aged

wild-type mice

Biashad, S. A., Hillpot, E., Morandini, F. ... · molecular biology ·

University of Rochester · biorxiv

Longevity Relevance Analysis (4)

Fucoidan supplementation activates SIRT6, leading to increased lifespan

and reduced frailty in aged mice. The paper is relevant as it

investigates a potential pharmacological approach to enhance longevity

through the activation of a protein associated with lifespan extension

and healthspan improvement.

The podcast is auto-generated by NotebookLM and frankly, has occasional mistakes on the date of the paper and the authors, but mostly describes the overall idea of the research and papers well. I'm trying it out for a few weeks to see if it's worth continuing to generate the podcast.

1. Inhibition of PIKfyve kinase induces senescent cell death by suppressing lysosomal exocytosis and leads to improved outcomes in a mouse model of idiopathic pulmonary fibrosis

https://www.biorxiv.org/content/10.11...

Authors: Barkovskaya, A., Kim, K., Shankar, A. et al.

Journal: Biorxiv

Institution: Lifespan Research Institute

Summary: This paper identifies PIKfyve kinase inhibition as a novel senolytic strategy that selectively kills senescent cells by blocking lysosomal exocytosis. The study demonstrates that the small molecule apilimod effectively removes senescent cells in vitro and in vivo, improving outcomes in a pulmonary fibrosis model. This research is highly relevant as it targets cellular senescence, a root cause of aging, and offers a potential therapeutic approach for age-related diseases.

Potential Impact: This paper could significantly impact the field by providing a new senolytic drug candidate with translational potential for treating age-related diseases.

2. Bcl-xL overexpression in T cells preserves muscle mitochondrial structure and function and prevents frailty in old mice

Paper: https://pubmed.ncbi.nlm.nih.gov/40106...

Authors: Cristina Mas-Bargues, Aurora Román-Domínguez, Jorge Sanz-Ros et al.

Journal: PubMed

Institution: Freshage Research Group, University of Valencia, Spain

Summary: This study shows that overexpression of the anti-apoptotic protein Bcl-xL in T cells enhances immune function, preserves mitochondrial integrity, and delays frailty in aging mice. The findings suggest that Bcl-xL plays a crucial role in healthy aging by improving cellular resilience and reducing inflammation.

Potential Impact: This research highlights the importance of immune system modulation in aging and could lead to new therapies targeting mitochondrial health and immune function to extend healthspan.

3. A Xanthine Derivative With Novel Heat Shock Protein 90-Alpha Inhibitory and Senolytic Properties

Paper: https://pubmed.ncbi.nlm.nih.gov/40098...

Authors: Sandra Atlante, Luca Cis, Davide Pirolli et al.

Journal: Aging Cell

Institution: Laboratory of Epigenetics, Istituti Clinici Scientifici Maugeri IRCCS, Italy

Summary: This paper introduces a novel xanthine derivative, K5, which exhibits significant senolytic activity and extends lifespan in model organisms. K5 targets HSP90α and selectively eliminates senescent cells, showing potential for combating age-related diseases and inflammaging.

Potential Impact: K5 represents a promising new senolytic compound with multimodal action, potentially offering a safer and more effective intervention for age-related diseases and lifespan extension.

4. TMBIM-2 orchestrates systemic mitochondrial stress response via facilitating Ca2+ oscillations

Paper:https://pubmed.ncbi.nlm.nih.gov/40100...

Authors: Jiasheng Li, Jimeng Cui, Xinyu Li et al.

Journal: PubMed

Institution: State Key Laboratory of Molecular Developmental Biology, Chinese Academy of Sciences

Summary: This study identifies TMBIM-2 as a key mediator of mitochondrial stress responses that influence aging and lifespan in C. elegans. TMBIM-2 regulates Ca2+ oscillations, which are critical for mitochondrial function and stress adaptation. Overexpression of TMBIM-2 counteracts age-related decline and extends lifespan.

Potential Impact: This research provides insights into the molecular mechanisms linking mitochondrial stress to aging and suggests TMBIM-2 as a potential target for interventions to counteract age-related decline.

5. Epigenetic age acceleration and mortality risk prediction in US adults

Paper: https://link.springer.com/article/10....

Authors: Angelico Mendy, Tesfaye B Mersha

Journal: GeroScience

Institution: University of Cincinnati College of Medicine

Summary: This paper examines the predictive power of epigenetic age acceleration (EAA) for all-cause, cardiovascular, and cancer mortality. The study demonstrates that EAA, particularly using the GrimAge clock, is a robust predictor of mortality risk, independent of chronological age.

Potential Impact: This research underscores the importance of epigenetic clocks in assessing biological aging and mortality risk, providing a tool for early intervention and personalized medicine in aging populations.

The podcast is auto-generated by NotebookLM and frankly, has occasional mistakes on the date of the paper and the authors, but mostly describes the overall idea of the research and papers well. I'm trying it out for a few weeks to see if it's worth continuing to generate the podcast.

Longevity Papers 2025-03-13

The Longevity Papers podcast focuses on the latest research papers in longevity biotech. This podcast episode covers a few of the tens of papers in https://longevitypapers.com, which finds the latest interesting papers with longevity focus from preprint servers.

The podcast is auto-generated by NotebookLM and frankly, has occasional mistakes on the date of the paper and the authors, but mostly describes the overall idea of the research and papers well. I'm trying it out for a few weeks to see if it's worth continuing to generate the podcast.

Longevity Papers 2025-03-06

The Longevity Papers podcast focuses on the latest research papers in longevity biotech. This podcast episode covers a few of the tens of papers in https://longevitypapers.com, which finds the latest interesting papers with longevity focus from preprint servers.

The podcast is auto-generated by NotebookLM and frankly, has occasional mistakes on the date of the paper and the authors, but mostly describes the overall idea of the research and papers well. I'm trying it out for a few weeks to see if it's worth continuing to generate the podcast.

Longevity Papers 2025-02-27

The Longevity Papers podcast focuses on the latest research papers in longevity biotech. This podcast episode covers a few of the tens of papers in https://longevitypapers.com, which finds the latest interesting papers with longevity focus from preprint servers.

The podcast is auto-generated by NotebookLM and frankly, has occasional mistakes on the date of the paper and the authors, but mostly describes the overall idea of the research and papers well. I'm trying it out for a few weeks to see if it's worth continuing to generate the podcast.

Longevity Papers 2025-02-20

The Longevity Papers podcast focuses on the latest research papers in longevity biotech. This podcast episode covers a few of the tens of papers in https://longevitypapers.com, which finds the latest interesting papers with longevity focus from preprint servers.

The podcast is auto-generated by NotebookLM and frankly, has occasional mistakes on the date of the paper and the authors, but mostly describes the overall idea of the research and papers well. I'm trying it out for a few weeks to see if it's worth continuing to generate the podcast.